Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.575
+0.025 (1.61%)
At close: Jul 30, 2026, 4:00 PM EDT
1.541
-0.034 (-2.15%)
After-hours: Jul 30, 2026, 7:59 PM EDT
Intelligent Bio Solutions Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 6.86 | 1.02 | 6.3 | 1.54 | 8.24 | 12.57 |
Cash & Short-Term Investments | 6.86 | 1.02 | 6.3 | 1.54 | 8.24 | 12.57 |
Cash Growth | 144.46% | -83.82% | 310.09% | -81.34% | -34.48% | 2842.78% |
Accounts Receivable | 0.88 | 0.59 | 0.43 | 0.29 | - | - |
Other Receivables | 0.57 | 0.73 | 0.53 | 0.5 | 1.88 | 3.12 |
Total Trade Receivables | 1.45 | 1.33 | 0.96 | 0.79 | 1.88 | 3.12 |
Inventory | 0.6 | 0.64 | 0.78 | 0.98 | - | - |
Other Current Assets | 0.84 | 1.15 | 0.5 | 0.55 | 0.75 | 2.51 |
Total Current Assets | 9.75 | 4.14 | 8.53 | 3.86 | 10.87 | 18.21 |
Net Property, Plant & Equipment | 2.11 | 0.32 | 0.87 | 1.24 | 0.39 | - |
Other Intangible Assets | 3 | 3.79 | 4.37 | 5.26 | - | - |
Other Long-Term Assets | - | - | - | - | 1.09 | 3.65 |
Total Assets | 14.86 | 8.25 | 13.78 | 10.35 | 12.35 | 21.86 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 3.64 | 4.53 | 1.7 | 2.61 | 1.63 | 1.48 |
Accrued Expenses | 0.59 | 0.53 | 0.47 | 0.36 | 0.2 | 0.1 |
Current Portion of Long-Term Debt | - | 0.2 | 0.52 | 0.35 | - | - |
Current Portion of Leases | 0.39 | 0.08 | 0.27 | 0.22 | - | - |
Unearned Revenue | - | - | 2.49 | 2.34 | 2.84 | 2.1 |
Total Current Liabilities | 4.61 | 5.35 | 5.45 | 5.88 | 4.66 | 3.68 |
Long-Term Debt | - | - | - | 0.4 | - | - |
Long-Term Leases | 1.46 | - | 0.08 | 0.36 | - | - |
Other Long-Term Liabilities | 0.04 | 0.08 | 0.06 | 0.02 | 1.14 | 3.17 |
Total Long-Term Liabilities | 1.5 | 0.08 | 0.14 | 0.78 | 1.14 | 3.17 |
Total Liabilities | 6.11 | 5.44 | 5.6 | 6.67 | 5.81 | 6.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Preferred Stock | - | - | - | - | - | 0.01 |
Common Stock | 0.02 | 0.07 | 0.03 | 0 | 0.01 | 0.14 |
Treasury Stock | -0 | -0 | -0 | -0 | - | - |
Additional Paid-in Capital | 80.5 | 65.78 | 60.97 | 46.18 | 38.58 | 38.44 |
Accumulated Other Comprehensive Income | -0.5 | -0.33 | -0.71 | -0.58 | -0.79 | -0.66 |
Retained Earnings | -71.06 | -62.53 | -51.96 | -41.81 | -31.18 | -22.87 |
Total Common Shareholders' Equity | 8.96 | 3 | 8.33 | 3.8 | 6.62 | 15.06 |
Minority Interest | -0.21 | -0.18 | -0.15 | -0.11 | -0.08 | -0.05 |
Shareholders' Equity | 8.75 | 2.81 | 8.18 | 3.69 | 6.55 | 15.01 |
Total Liabilities & Equity | 14.86 | 8.25 | 13.78 | 10.35 | 12.35 | 21.86 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 1.85 | 0.28 | 0.87 | 1.34 | 0 | 0 |
Net Cash (Debt) | 5.01 | 0.74 | 5.43 | 0.2 | 8.24 | 12.57 |
Net Cash Growth | 118.38% | -86.41% | 2595.32% | -97.55% | -34.48% | - |
Net Cash Per Share | 4.89 | 1.40 | 34.11 | - | - | - |
Book Value | 8.96 | 3 | 8.33 | 3.8 | 6.62 | 15.06 |
Book Value Per Share | 8.74 | 5.68 | 52.30 | - | - | - |
Tangible Book Value | 5.96 | -0.79 | 3.96 | -1.46 | 6.62 | 15.06 |
Tangible Book Value Per Share | 5.82 | -1.51 | 24.85 | - | - | - |